Last Week’s Top 10 Stocks Post Double-Digit Gains

8. Tempus AI Inc. (NASDAQ:TEM)

Tempus AI grew its share prices by 29.7 percent week-on-week to end Friday’s trading at $89.44 apiece versus the $68.96 on February 7, as investors gobbled up shares in the company after sealing a deal with the nonprofit organization Institute for Follicular Lymphoma Innovation (IFLI).

In a statement, TEM said the partnership aims to develop targeted therapies for the disease through developing a real-world multimodal, de-identified FL data library in its data analytics platform, through which researchers may derive AI-driven insights to accelerate the development of FL treatments in an effort to improve patient outcomes.

TEM said the two parties will focus on prospectively generating multimodal FL data, particularly for POD24 patients who experience disease progression within 24 months of treatment.

Data from the National Cancer Institute as of 2024 showed that FL is most frequently diagnosed among people aged 65 to 74 and that the survival rate is currently at 89.9 percent.